Financial Performance - The company's revenue for Q3 2024 was ¥424,481,759.33, a decrease of 3.63% compared to the same period last year[2]. - Net profit attributable to shareholders was ¥7,420,504.16, down 87.80% year-over-year[2]. - The net profit after deducting non-recurring gains and losses was ¥3,258,299.50, a decline of 94.30% compared to the previous year[2]. - The basic earnings per share decreased to ¥0.06, down 88.24% compared to the same period last year[2]. - Net profit for Q3 2024 was ¥87,272,527.89, a decrease of 40% from ¥145,194,466.08 in Q3 2023[15]. - The company reported a basic earnings per share of ¥0.59, down from ¥1.21 in the same quarter last year[15]. - The total comprehensive income for Q3 2024 was ¥86,480,039.35, compared to ¥145,939,270.08 in Q3 2023, showing a significant decline[15]. Revenue and Costs - The company reported a 5.36% increase in revenue for the first nine months of 2024, totaling ¥1,214,136,418.29[5]. - Total operating revenue for Q3 2024 reached ¥1,214,136,418.29, an increase of 5.37% compared to ¥1,152,410,377.92 in the same period last year[13]. - Total operating costs amounted to ¥1,131,833,074.67, up 14.39% from ¥988,856,611.77 in the previous year[14]. Assets and Liabilities - Total assets increased to ¥3,471,987,083.26, reflecting a growth of 6.19% from the end of the previous year[2]. - The company's total liabilities increased to ¥1,255,536,348.21, compared to ¥1,169,968,302.97 in the previous year, reflecting a growth of 7.31%[12]. - The company's total liabilities decreased by 2.73% in accounts payable, amounting to ¥649,173,209.85[5]. - The total equity attributable to shareholders of the parent company rose to ¥2,136,833,238.87, up from ¥2,099,614,459.15, marking an increase of 1.77%[12]. Cash Flow - The company's cash flow from operating activities showed a net increase of ¥23,065,087.79, a significant improvement of 122.32% year-over-year[5]. - Operating cash flow for the period was ¥23,065,087.79, a significant improvement from a negative cash flow of -¥103,358,796.00 in the previous period[17]. - Total cash inflow from operating activities was ¥1,110,538,853.79, slightly down from ¥1,118,104,327.78 in the prior period[17]. - Cash inflow from financing activities was ¥672,465,520.70, a substantial increase from ¥69,695,555.56 in the previous period[18]. - Net cash flow from financing activities was ¥82,248,861.49, compared to ¥37,085,778.23 in the prior period, reflecting improved financing conditions[18]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,341[7]. - Jiangsu Shangkun Biological Equipment Co., Ltd. holds 29.08% of shares, totaling 34,890,248 shares[7]. - The company has a repurchase account holding 999,936 shares among the top 10 shareholders[8]. - The top 10 shareholders include state-owned and private entities, with the largest shareholder being Jiangsu Shangkun Biological Equipment Co., Ltd.[9]. Expenses - The company experienced a 35.89% increase in management expenses, totaling ¥60,314,105.19, attributed to the consolidation of Jiangzhou Auto Parts Factory[5]. - Research and development expenses for the period were ¥57,588,177.15, slightly higher than ¥55,021,068.61 in the previous year, indicating a focus on innovation[14]. - Cash paid to employees increased to ¥115,874,804.40 from ¥92,892,255.76, reflecting higher labor costs[17]. - Cash paid for taxes rose to ¥50,772,093.55 from ¥25,760,998.11, indicating increased tax obligations[17]. Inventory and Receivables - The accounts receivable increased from ¥525,567,853.73 to ¥579,299,705.96, a rise of about 10.2%[11]. - The inventory decreased from ¥316,121,178.38 to ¥297,503,787.69, a reduction of approximately 5.9%[11]. Investment Activities - Total cash inflow from investment activities was ¥1,674,757,294.40, compared to ¥969,769,190.81 in the prior period, indicating a strong increase[17]. - Cash outflow from investment activities rose to ¥1,944,148,050.89, up from ¥774,191,211.99, resulting in a net cash flow from investment activities of -¥269,390,756.49[17].
通灵股份(301168) - 2024 Q3 - 季度财报